Meta-Analysis
Copyright ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Feb 22, 2019; 7(2): 51-65
Published online Feb 22, 2019. doi: 10.13105/wjma.v7.i2.51
Evaluation of tumor response to antiangiogenic therapy in patients with recurrent gliomas using contrast-enhanced perfusion-weighted magnetic resonance imaging techniques: A meta-analysis
Akanganyira Kasenene, Aju Baidya, Salman Shams, Hai-Bo Xu
Akanganyira Kasenene, Aju Baidya, Salman Shams, Hai-Bo Xu, Department of Radiology and Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, Hubei Province, China
Author contributions: Kasenene A and Baidya A contributed equally to this work; Kasenene A and Xu HB designed this study; Kasenene A and Baidya A analyzed the data; Kasenene A, Baidya A, Shams S, and Xu HB drafted the paper.
Conflict-of-interest statement: There is no conflict of interest.
PRISMA 2009 Checklist statement: The current manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Hai-Bo Xu, MD, PhD, Director, Doctor, Professor, Teacher, Department of Radiology and Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan 430071, Hubei Province, China. xuhaibo1120@hotmail.com
Telephone: +86-27-67812533 Fax: +86-27-67812533
Received: January 16, 2019
Peer-review started: January 16, 2019
First decision: January 30, 2019
Revised: February 7, 2019
Accepted: February 13, 2019
Article in press: February 14, 2019
Published online: February 22, 2019
Processing time: 35 Days and 20.7 Hours
Core Tip

Core tip: Perfusion-weighted magnetic resonance imaging is one of the advanced magnetic resonance (MR) techniques which offer non-invasive and effective ways of grading, differentiating, and assessing therapeutic response and prognosis of brain tumors. This meta-analysis evaluates the clinical applicability of this MR technique in the assessment of the response of recurrent gliomas to antiangiogenic therapy.